Search

Zimmer Biomet Holdings Inc

Slēgts

SektorsVeselības aprūpe

95 0.81

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

95

Max

95.82

Galvenie mērījumi

By Trading Economics

Ienākumi

-39M

200M

Pārdošana

90M

2.2B

P/E

Sektora vidējais

23.432

56.432

EPS

2.07

Dividenžu ienesīgums

1.03

Peļņas marža

9.169

Darbinieki

17,000

EBITDA

-210M

328M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+11.23% upside

Dividendes

By Acuity

Dividenžu ienesīgums

Sektora vidējais

1.03%

2.27%

Nākamie ieņēmumi

2026. g. 4. nov.

Nākamais dividenžu datums

2026. g. 30. okt.

Nākamais Ex dividenžu datums

2026. g. 29. sept.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-348M

18B

Iepriekšējā atvēršanas cena

94.19

Iepriekšējā slēgšanas cena

95

Ziņu noskaņojums

By Acuity

25%

75%

28 / 339 Rangs Healthcare

Zimmer Biomet Holdings Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 18. sept. 21:51 UTC

Zimmer Biomet Holdings, Inc. is advancing in after-market trading, moving higher alongside the broader market despite concerns over U.S. economic momentum.

2026. g. 16. sept. 20:07 UTC

Zimmer Biomet Holdings, Inc. shares fell sharply, retracing from earlier gains and remaining below the 20-day moving average amid a decline since Tuesday's close.

2026. g. 15. sept. 20:03 UTC

Zimmer Biomet shares are higher today, continuing positive momentum from Monday. This follows an early dip amid broader market concerns over New York's manufacturing sector.

2026. g. 14. sept. 22:01 UTC

Zimmer Biomet Holdings shares are higher in after-market trading, continuing a trend of gains since Monday's close. No specific news was identified.

2026. g. 11. sept. 23:46 UTC

Zimmer Biomet Holdings shares advanced in after-market trading, recovering from earlier losses. The stock remains below its 20-day moving average.

2026. g. 10. sept. 20:03 UTC

Zimmer Biomet Holdings is declining during Thursday's session, continuing a downward trend since Wednesday's close with no specific news identified for the movement.

2026. g. 9. sept. 22:51 UTC

Zimmer Biomet Holdings is trading lower in after-market hours amid a broader decline in U.S. stocks linked to rising crude oil prices above $100.

2026. g. 8. sept. 21:02 UTC

News

Zimmer Biomet announced leadership promotions to enhance its strategy and reaffirmed its 2026 financial outlook. Shares are higher in after-market trading.

2026. g. 4. sept. 20:07 UTC

Shares of Zimmer Biomet Holdings are lower today, amid increased selling pressure following a strong jobs report. The stock remains below its 20-day moving average.

2026. g. 2. sept. 20:08 UTC

Zimmer Biomet shares are higher today, benefiting from significant advances in Health Care Equipment stocks. No specific news was identified to explain the movement.

2026. g. 1. sept. 21:51 UTC

Zimmer Biomet Holdings shares are higher in after-market trading, nearing the top of their one-month range, amid broader market volatility and rising crude oil prices.

2026. g. 31. aug. 20:07 UTC

Shares of Zimmer Biomet Holdings are trading lower amid market pressure from heightened interest rate hike expectations following the Jackson Hole Economic Symposium.

2026. g. 28. aug. 19:16 UTC

Zimmer Biomet Holdings is trading higher during Friday's session, maintaining a position above its 20-day moving average and near the upper end of its one-month range.

2026. g. 27. aug. 20:02 UTC

Zimmer Biomet Holdings, Inc. shares are lower as Health Care Equipment stocks face pressure, marking a shift from recent upward trends. No specific news was identified.

2026. g. 26. aug. 19:26 UTC

Zimmer Biomet Holdings is trading higher, supported by strength above its 20-day moving average amid broader market dynamics and rising U.S. consumer prices.

2026. g. 25. aug. 23:31 UTC

Zimmer Biomet Holdings is trading lower in after-market hours. This decline comes amid broader market sentiment impacted by a significant drop in crude oil prices.

2026. g. 24. aug. 19:46 UTC

Zimmer Biomet Holdings is trading higher today, with shares near the upper end of their one-month range amid rising oil prices and geopolitical tensions.

2026. g. 22. aug. 00:01 UTC

Zimmer Biomet Holdings Inc. shares are lower in after-market hours, reflecting broader weakness despite remaining above the 20-day moving average.

2026. g. 21. aug. 23:01 UTC

Zimmer Biomet Holdings Inc shares are lower in after-market hours, with no specific news identified. Recent bond market volatility may be influencing trader sentiment.

2026. g. 19. aug. 20:06 UTC

Zimmer Biomet Holdings Inc is trading higher today, marking a shift from its recent trend of higher daily closes since Tuesday. No specific news was identified.

2026. g. 18. aug. 19:16 UTC

Correlated Moves

Zimmer Biomet Holdings Inc. reported first-quarter revenue of $2.05 billion, exceeding estimates. Shares are advancing amid raised full-year guidance and positive sector sentiment.

2026. g. 17. aug. 20:02 UTC

Zimmer Biomet Holdings Inc shares are lower today, continuing a decline since Friday amid broader market pressures and rising crude oil prices.

2026. g. 14. aug. 19:26 UTC

News

Zimmer Biomet Holdings Inc. shares are higher following Q2 earnings that topped estimates, with revenue of $2.18 billion and adjusted EPS of $2.07.

2026. g. 13. aug. 19:46 UTC

Shares of Zimmer Biomet Holdings are trading higher, remaining strong near the upper end of their one-month range amid positive broader market sentiment.

2026. g. 12. aug. 23:21 UTC

Zimmer Biomet Holdings Inc. shares are roughly flat in after-market trading, remaining above their 20-day moving average and near the upper end of their one-month range.

2026. g. 11. aug. 23:02 UTC

Zimmer Biomet Holdings Inc. shares are higher in after-market trading, moving within a range above its 20-day moving average and near a one-month high.

2026. g. 10. aug. 19:56 UTC

Correlated Moves
News

Canaccord raised Zimmer Biomet's price target to $100 from $83, maintaining a Hold rating. Shares are higher since Friday's close amid market strength.

2026. g. 7. aug. 19:46 UTC

News

Zimmer Biomet shares are lower today as Truist maintains a Hold rating but raises the price target to $106 amid cautious market conditions.

2026. g. 6. aug. 19:52 UTC

News

Zimmer Biomet shares are lower today, despite price target increases from RBC, BMO, and Wells Fargo. This marks a shift from recent higher daily closes.

2026. g. 5. aug. 23:02 UTC

News

Stifel raised the price target on Zimmer Biomet to $110 from $105, maintaining a Buy rating. Shares are higher in after-market trading.

Salīdzinājums

Cenas izmaiņa

Zimmer Biomet Holdings Inc Prognoze

Cenas mērķis

By TipRanks

11.23% augšup

Prognoze 12 mēnešiem

Vidējais 106.067 USD  11.23%

Augstākais 120 USD

Zemākais 93 USD

Pamatojoties uz 18 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Zimmer Biomet Holdings Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

18 ratings

6

Pirkt

12

Turēt

0

Pārdot

Noskaņojums

By Acuity

28 / 339 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.